Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2021 | Survivorship challenges in prostate cancer

Silke Gillessen • 17 Sep 2021
ESMO 2021
Genitourinary Cancer Prostate Cancer

Silke Gillessen, MD, PhD, University of Lugano, Lugano, Switzerland and the Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, outlines challenges in survivorship for men with prostate cancer, highlighting the toxicities associated with androgen deprivation therapy including bone health. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.

More from Silke Gillessen

2:30
PARP inhibitors plus novel endocrine agents for patients with metastatic prostate cancer
Silke Gillessen • 18 Feb 2023
1:23
The role of immune checkpoint inhibitors in mCRPC
Silke Gillessen • 18 Feb 2023
2:12
Criteria for treatment selection for patients with CRPC
Silke Gillessen • 18 Feb 2023
2:43
Treatment sequencing and combinations for prostate cancer
Silke Gillessen • 18 Feb 2023

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals